Liberal versus restrictive transfusion strategy in critically III oncologic patients: The transfusion requirements in critically III oncologic patients randomized controlled trial

Critical Care Medicine

Volumn 45, Issue 5, 2017, Pages 766-773

  Bergamin, Fabricio S ^a   Almeida, Juliano P ^a   Landoni, Giovanni ^b   Galas, Filomena R B G ^a   Fukushima, Julia T ^a   Fominskiy, Evgeny ^b   Park, Clarice H L ^a   Osawa, Eduardo A ^a   Diz, Maria P E ^a   Oliveira, Gisele Q ^a   Franco, Rafael A ^a   Nakamura, Rosana E ^a   Almeida, Elisangela M ^a   Abdala, Edson ^c   Freire, Maristela P ^c   Filho, Roberto K ^a   Auler, Jose Otavio C ^a   Hajjar, Ludhmila A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Instituto do Cancer do Estado de São Paulo   (Brazil)

Author keywords

Critically ill oncology; Intensive care; Randomized controlled trial; Transfusion

Indexed keywords

ANTINEOPLASTIC AGENT; FRESH FROZEN PLASMA; HEMOGLOBIN; INOTROPIC AGENT;

ABDOMINAL INFECTION; ACUTE HEART INFARCTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION REACTION; BRAIN CANCER; BRAIN DYSFUNCTION; BRAIN ISCHEMIA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CRYOPRECIPITATE; DIGESTIVE SYSTEM CANCER; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; HEAD AND NECK CANCER; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; LENGTH OF STAY; LIMB ISCHEMIA; LIVER FAILURE; LUNG CANCER; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MESENTERIC ISCHEMIA; MORTALITY RATE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY; URINARY TRACT INFECTION; UROGENITAL TRACT CANCER; AGED; CRITICAL ILLNESS; INTENSIVE CARE UNIT; MIDDLE AGED; MORTALITY; NEOPLASMS; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNIVERSITY HOSPITAL;

AGED; CRITICAL CARE; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TIME FACTORS;

EID: 85014043870     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002283     Document Type: Article

References (30)

1. Singer M, Deutschman CS, Seymour CW, et al: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801-810.
2. de Montmollin, E, Tandjaoui-Lambiotte Y, Legrand M, et al: Outcomes in critically ill cancer patients with septic shock of pulmonary origin. Shock 2013; 39:250-254.
3. Pène F, Percheron S, Lemiale V, et al: Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008; 36:690-696.
4. Regazzoni CJ, Irrazabal C, Luna CM, et al: Cancer patients with septic shock: Mortality predictors and neutropenia. Support Care Cancer 2004; 12:833-839.
5. Rosolem MM, Rabello LS, Lisboa T, et al: Critically ill patients with cancer and sepsis: Clinical course and prognostic factors. J Crit Care 2012; 27:301-307.
6. Danai PA, Moss M, Mannino DM, et al: The epidemiology of sepsis in patients with malignancy. Chest 2006; 129:1432-1440.
7. Staudinger T, Pène F: Current insights into severe sepsis in cancer patients. Rev Bras Ter Intensiva 2014; 26:335-338.
8. Mayr FB, Yende S, Angus DC: Epidemiology of severe sepsis. Virulence 2014; 5:4-11.
9. Hébert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417.
10. Hajjar LA, Vincent JL, Galas FR, et al: Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 2010; 304:1559-1567.
11. Villanueva C, Colomo A, Bosch A, et al: Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368:11-21.
12. Vincent JL: Indications for blood transfusions: Too complex to base on a single number? Ann Intern Med 2012; 157:71-72.
13. Carson JL, Carless PA, Hebert PC: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4:CD002042.
14. Chatterjee S, Wetterslev J, Sharma A, et al: Association of blood transfusion with increased mortality in myocardial infarction: A metaanalysis and diversity-Adjusted study sequential analysis. JAMA Intern Med 2013; 173:132-139.
15. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637.
16. Angus DC: The search for effective therapy for sepsis: Back to the drawing board? JAMA 2011; 306:2614-2615.
17. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256.
18. Corwin HL, Gettinger A, Pearl RG, et al: The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004; 32:39-52.
19. Vincent JL, Baron JF, Reinhart K, et al; ABC (Anemia and Blood Transfusion in Critical Care) Investigators: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507.
20. Holst LB, Haase N, Wetterslev J, et al; TRISS Trial Group; Scandinavian Critical Care Trials Group: Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371:1381-1391.
21. Soares M, Caruso P, Silva E, et al; Brazilian Research in Intensive Care Network (BRICNet): Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study. Crit Care Med 2010; 38:9-15.
22. Hovaguimian F, Myles PS: Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: A context-specific systematic review and meta-Analysis of randomized controlled trials. Anesthesiology 2016; 125:46-61.
23. Ridgeon EE, Young PJ, Bellomo R, et al: The fragility index in multicenter randomized controlled critical care trials. Crit Care Med 2016; 44:1278-1284.
24. Holst LB, Petersen MW, Haase N, et al: Restrictive versus liberal transfusion strategy for red blood cell transfusion: Systematic review of randomised trials with meta-Analysis and trial sequential analysis. BMJ 2015; 350:h1354.
25. de Almeida, JP, Vincent JL, Galas FR, et al: Transfusion requirements in surgical oncology patients: A prospective, randomized controlled trial. Anesthesiology 2015; 122:29-38.
26. Murphy GJ, Pike K, Rogers CA, et al; TITRe2 Investigators: Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372:997-1008.
27. Gregersen M, Borris LC, Damsgaard EM: Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: The TRIFE randomized controlled trial. Acta Orthop 2015; 86:363-372.
28. Park DW, Chun BC, Kwon SS, et al: Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: A propensity-matched analysis. Crit Care Med 2012; 40:3140-3145.
29. Vincent JL, Sakr Y, Sprung C, et al; Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators: Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology 2008; 108:31-39.
30. Carson JL, Terrin ML, Noveck H, et al; FOCUS Investigators: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453-2462.